XPO1 and chronic myelogenous leukemia, BCR-ABL1 positive: While there was no difference between K562 and K562G for CRM1 expression, the IM-resistant primary CML cell showed markedly higher CRM1 expression than IM-sensitive primary cells (Fig. 1b, c).